The combined tumor markers CA19-9, CA125, leptin, thymidine kinase, CEA, CA15-3, and HE4 have been shown to have a 95% sensitivity and a 96% specificity for detecting EC. This evidence concerns the gene CEACAM5 and neoplasm.